Li Xue Selected Research

erythroid Kruppel-like factor

1/2017	Neomorphic effects of the neonatal anemia (Nan-Eklf) mutation contribute to deficits throughout development.
1/2016	EKLF/KLF1-regulated cell cycle exit is essential for erythroblast enucleation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Li Xue Research Topics

Disease

32	Neoplasms (Cancer) 05/2022 - 07/2003
9	Parkinson Disease (Parkinson's Disease) 03/2021 - 09/2012
8	Inflammation (Inflammations) 03/2022 - 12/2009
8	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2015
7	Prostatic Neoplasms (Prostate Cancer) 03/2022 - 01/2015
6	Carcinogenesis 01/2021 - 01/2015
5	Rheumatoid Arthritis 03/2022 - 07/2013
5	Myocardial Infarction 01/2022 - 06/2010
5	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2015
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2010
5	Reperfusion Injury 11/2019 - 11/2011
5	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2019 - 06/2013
4	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 11/2008
4	Ischemia 01/2021 - 11/2011
4	Atherosclerosis 01/2020 - 01/2018
3	Leukemia 01/2022 - 01/2017
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 09/2012
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 02/2012
3	Hypertension (High Blood Pressure) 01/2020 - 01/2015
3	Atherosclerotic Plaque (Atheroma) 01/2019 - 11/2014
3	Coronary Artery Disease (Coronary Atherosclerosis) 03/2015 - 11/2007
3	Type 2 Diabetes Mellitus (MODY) 01/2012 - 12/2005
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2021
2	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 01/2021
2	Urinary Bladder Neoplasms (Bladder Cancer) 08/2021 - 06/2013
2	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 01/2021
2	Pituitary Neoplasms (Pituitary Adenoma) 01/2021 - 01/2020
2	Stomach Neoplasms (Stomach Cancer) 09/2020 - 08/2016
2	Osteosarcoma (Osteogenic Sarcoma) 01/2020 - 10/2016
2	Neuroinflammatory Diseases 01/2020 - 08/2019
2	Heart Valve Diseases (Valvular Heart Disease) 11/2019 - 12/2016
2	Non-alcoholic Fatty Liver Disease 11/2018 - 01/2017
2	Acute Coronary Syndrome 01/2018 - 09/2011
2	Carbon Monoxide Poisoning (Poisoning, Carbon Monoxide) 03/2017 - 11/2016
2	Poisoning 03/2017 - 11/2016
2	Anemia 01/2017 - 01/2016
2	Myocardial Ischemia (Ischemic Heart Diseases) 12/2016 - 03/2013
2	Hypoxia (Hypoxemia) 10/2016 - 03/2015
2	Coronary Disease (Coronary Heart Disease) 06/2016 - 08/2007
2	Diabetes Mellitus 02/2016 - 12/2005
2	Wounds and Injuries (Trauma) 02/2016 - 06/2010
2	Asthma (Bronchial Asthma) 01/2015 - 11/2011
1	Prostatitis 03/2022

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2012
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2017
8	Pharmaceutical PreparationsIBA 01/2021 - 08/2013
7	CytokinesIBA 01/2021 - 11/2011
7	Aldehyde DehydrogenaseIBA 01/2021 - 09/2011
6	Biological ProductsIBA 01/2022 - 05/2016
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 07/2012
5	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 11/2016
5	Messenger RNA (mRNA)IBA 01/2020 - 01/2013
3	Toll-Like Receptor 4IBA 03/2022 - 01/2017
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2015
3	CateninsIBA 11/2021 - 01/2021
3	AldehydesIBA 01/2021 - 08/2007
3	ChemokinesIBA 01/2021 - 11/2011
3	Apolipoproteins E (ApoE)IBA 01/2019 - 06/2016
3	omega-Chloroacetophenone (Mace)IBA 03/2018 - 04/2010
3	AntibodiesIBA 01/2018 - 07/2013
3	Therapeutic UsesIBA 05/2017 - 12/2006
3	RNA (Ribonucleic Acid)IBA 11/2016 - 01/2013
3	Interleukin-13IBA 01/2015 - 12/2009
2	Prostate-Specific Antigen (Semenogelase)IBA 03/2022 - 02/2021
2	Dopamine D3 ReceptorsIBA 03/2022 - 10/2018
2	CD100 antigenIBA 01/2022 - 01/2021
2	Nerve Growth Factors (Neurotrophins)IBA 01/2022 - 01/2020
2	Antidepressive Agents (Antidepressants)IBA 01/2022 - 01/2021
2	Schiff Bases (Schiff Base)IBA 11/2021 - 01/2021
2	2-vanillinIBA 11/2021 - 01/2021
2	LigandsIBA 11/2021 - 01/2021
2	VALD-3IBA 11/2021 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 08/2021 - 12/2010
2	Beclin-1IBA 01/2021 - 01/2019
2	oxidized low density lipoproteinIBA 01/2020 - 03/2013
2	Estrogens (Estrogen)FDA Link 01/2020 - 03/2006
2	LipopolysaccharidesIBA 01/2020 - 01/2017
2	Carnitine (L-Carnitine)FDA LinkGeneric 11/2019 - 12/2016
2	Propranolol (Inderal)FDA LinkGeneric 01/2019 - 01/2018
2	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2019 - 01/2018
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2018 - 03/2015
2	LipidsIBA 01/2018 - 06/2016
2	Oxygen (Dioxygen)IBA 03/2017 - 11/2016
2	erythroid Kruppel-like factorIBA 01/2017 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2016 - 02/2010
2	Immunologic Factors (Immunomodulators)IBA 09/2016 - 09/2012
2	Oxidoreductases (Dehydrogenase)IBA 05/2016 - 03/2013
2	ProstaglandinsIBA 05/2016 - 07/2003
2	BilirubinIBA 01/2015 - 08/2012
2	Codon (Codons)IBA 07/2012 - 06/2010
2	C-Reactive ProteinIBA 09/2011 - 06/2010
2	3-n-butylphthalide (butylphthalide)IBA 09/2010 - 02/2010
1	Dopamine Receptors (Dopamine Receptor)IBA 03/2022

Therapy/Procedure

15	Therapeutics 01/2022 - 12/2006
5	Drug Therapy (Chemotherapy) 01/2021 - 04/2007
4	Aftercare (After-Treatment) 05/2017 - 07/2003
3	Radiotherapy 01/2021 - 04/2007
3	Percutaneous Coronary Intervention 03/2018 - 04/2010
2	Percutaneous Collagen Induction 05/2017 - 12/2006
1	Immunotherapy 05/2022